In the biopharmaceutical industry, cell processing refers to the various techniques used to culture, harvest, and purify therapeutic cells and proteins from living cellular systems. As new biologics continue to reshape medical treatment, cell processing plays a crucial role in supporting the large-scale, consistent manufacture of these complex biological drugs. The development of advanced cell processing methods has been integral to making cell and gene therapies a clinical and commercial reality.

Cell Culture Techniques
One of the first major steps in Cell Processing is establishing and maintaining cell cultures. Therapeutic cells must be grown efficiently and uniformly in controlled bioreactors. Process developers work to optimize culture conditions like media formulations, oxygen levels, temperature, pH, and agitation. Suspension cultures are common for bacterial and mammalian cell lines used to produce monoclonal antibodies or viral vectors. Adherent cell types require surfaces like microcarriers or hollow fiber membranes for attachment and proliferation. Ensuring sterile, viable cell cultures lays the groundwork for consistent and optimized downstream processes.

Harvesting and Separation
Once cultured cells reach their desired density and metabolic state, the next phase is carefully collecting and separating them from their growth environment. Centrifugation is a standard method to pelletize cells, while alternative techniques like tangential flow filtration concentrates cells while exchanging media. Post-harvest processing may utilize dissociation enzymes to detach adherent cells prior to separation. Cell purifications at this stage aim to maximize viable cell recoveries while removing contaminants from disrupted cell debris or residual reagents.

Purification and Formulation
Further purification steps work to isolate the therapeutic protein, virus, or cell product from culture fluids and cell lysates. Chromatography utilizes different physical properties to separate molecules through stationary phases like size exclusion, ion exchange, affinity, or hydrophobic interaction media. Other methods provide orthogonal purification capabilities through techniques such as precipitation, filtration, or viral inactivation treatments. The final drug substance is formulated into stable frozen or liquid suspensions appropriate for downstream manufacturing or clinical administration.

Continuous Processing Advances
Recent efforts focus on developing integrated, continuous methods that improve efficiencies of batch-based cell processing. Continuous bioreactors optimize cell culture conditions and allow uninterrupted harvesting. Coupled with continuous downstream modalities like packed-bed chromatography and tangential flow filtration, entire manufacturing trains can operate without interruptions. At larger scales, continuous processes minimize waste generations and facility footprints while enhancing productivities. Their implementation aims to further cut production costs and times for emerging modalities.

Get more insights on Cell Processing